Actively Recruiting
Brief Title: Aerobic Training on Cerebrovascular Function, Cognition and Gait in Parkinson's Disease
Led by Raphael Mendes Ritti Dias · Updated on 2026-04-13
40
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This randomized controlled trial will investigate the effects of a 12-week supervised aerobic training program on cerebrovascular function, peripheral vascular health, cardiovascular autonomic modulation, cognition, non-motor symptoms, sleep, mood, gait biomechanics, quality of life, and body composition in patients with Parkinson's disease (Hoehn \& Yahr stages 1-3). Participants will be randomly allocated to aerobic training or usual care.
CONDITIONS
Official Title
Brief Title: Aerobic Training on Cerebrovascular Function, Cognition and Gait in Parkinson's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of Parkinson's disease
- Hoehn & Yahr stages 1 to 3
- Stable antiparkinsonian medication for at least 4 weeks
- Montreal Cognitive Assessment (MoCA) score of 18 or higher
- Ability to walk independently, with or without assistive device
- Medical clearance to participate in moderate-intensity exercise
You will not qualify if you...
- Recent change in medication
- Any contraindication to exercise
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Associação Brasil Parkinson
São Paulo, São Paulo, Brazil, 04142-092
Actively Recruiting
Research Team
R
Raphael M Ritti-Dias, PhD
CONTACT
H
Hélcio Kanegusuku, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here